COVID-19Surg[11 COVIDSurg Collaborative; GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021;76(6):748-58. doi:10.1111/anae.15458. https://doi.org/10.1111/anae.15458...
] |
To determine the optimal waiting time between COVID-19 infection and surgery |
Prospective cohort, international, multicentric |
3,127 |
October 2020 |
All types of surgery |
0–2 weeks (1,138), 3–4 weeks (461), 5–6 weeks, and ≥ 7 weeks (1,202) |
With > 7 weeks, similar morbidity to control group |
With > 7 weeks, similar mortality to control group |
Carrier[77 Carrier FM, Amzallag É, Lecluyse V, Côté G, Couture ÉJ, D'Aragon F, et al. Postoperative outcomes in surgical COVID-19 patients: a multicenter cohort study. BMC Anesthesiol. 2021;21(1):15. doi:10.1186/s12871-021-01233-9. https://doi.org/10.1186/s12871-021-01233...
] |
Primary: characteristics and evolution of COVID-19-infected patients who required surgery
Secondary: characteristics of patients who have recovered from infection and require surgery
|
Prospective cohort. Multicentric in Quebec, Canada |
44 |
March-June 2020 |
All types of non-cardiac surgery |
Does not discriminate. All patients were asymptomatic at the time of surgery or had more than 14 days of negative PCR |
Complications were high in patients with COVID-19 at the time of surgery, especially in symptomatic patients.
In recovered patients, morbidity was lower and similar between them. Events were similar with symptomatic COVID-19 and non-symptomatic COVID-19
|
It was higher in symptomatic COVID-19 |
Kho R[99 Kho RM, Chang OH, Hare A, Schafer J, Hamner J, Northington GM, et al. Surgical outcomes in benign gynecologic surgery patients during the COVID-19 pandemic (SOCOVID study). J Minim Invasive Gynecol. 2022;29(2):274-83.e1. doi:10.1016/j.jmig.2021.08.011. https://doi.org/10.1016/j.jmig.2021.08.0...
] |
Morbidity and mortality of a subgroup of surgeries postponed due to COVID-19 |
Prospective. Multicentric in the United States of America |
114 |
July to December 2020 |
Gynecological surgery |
Mean 98.3±64 days |
The COVID-19-postponed subgroup showed no difference from the non-COVID-19 group |
No data |
Welk B[1010 Welk B, Richard L, Rodriguez-Elizalde S. The requirement for surgery and subsequent 30-day mortality in patients with COVID-19. Can J Surg. 2021;64(2):E246-8. doi:10.1503/cjs.022020. https://doi.org/10.1503/cjs.022020...
] |
Postoperative mortality in the early and late period after diagnosis of COVID-19-19 |
Retrospective. Database analysis in Ontario, Canada |
146 |
February and May 2020 |
All types of surgery, including heart surgery |
Within 14 days or later |
Mortality was significantly lower in patients who underwent surgery 15-60 days after COVID-19 diagnosis |
19.7% (£ 14 days) and 6.2% (after 15 days) |
Nedelu M[1111 Nedelcu M, Marx L, Lutf RE, Vilallonga R, Diaconu V, Aboudi S, et al. Bariatric surgery in patients with previous COVID-19 infection. Surg Obes Relat Dis. 2021;17(7):1244-8. doi:10.1016/j.soard.2021.03.029. https://doi.org/10.1016/j.soard.2021.03....
] |
Postoperative complications |
Retrospective. Multicentric. Europe. |
35 |
June-October 2020 |
Bariatric surgery |
Mean of 11.3 weeks (3-43 weeks) |
No complications related to infection in the first 30 days |
No mortality |
VosburgW[1212 Vosburg RW, Pratt JSA, Kindel T, Rogers AM, Kudav S, Banerjee A, et al. Bariatric surgery is safe for patients after recovery from COVID-19. Surg Obes Relat Dis. 2021;17(11):1884-9. doi:10.1016/j.soard.2021.07.018. https://doi.org/10.1016/j.soard.2021.07....
] |
Morbidity and mortality in patients who had COVID-19 and recovered |
Retrospective. Multicentric in the United States of America |
53 |
No data |
Bariatric surgery |
54 days for asymptomatic and 102 days for mild symptoms. The average waiting time was 82 days. |
No complications |
No mortality |
Gomez O[1313 Gomes WJ, Rocco I, Pimentel WS, Pinheiro AHB, Souza PMS, Costa LAA, et al. COVID-19 in the perioperative period of cardiovascular surgery: the Brazilian experience. Braz J Cardiovasc Surg. 2021;36(6):725-35. doi:10.21470/1678-9741-2021-0960. https://doi.org/10.21470/1678-9741-2021-...
] |
Evolution of patients who presented COVID-19 in the perioperative period |
Retrospective. Multicentric in Brazil |
104 |
March 2020 – July 2021 |
Cardiac surgery |
Mean 48 ±51 days before surgery in the group that had COVID-19 before surgery |
Patients operated after 10 days of COVID-19 had lower morbidity |
Surgery after 10 days of COVID-19 had lower mortality |
Knisley[1414 Knisely A, Zhou ZN, Wu J, Huang Y, Holcomb K, Melamed A, et al. Perioperative morbidity and mortality of patients with COVID-19 who undergo urgent and emergent surgical procedures. Ann Surg. 2021;273(1):34-40. doi:10.1097/SLA.0000000000004420. https://doi.org/10.1097/SLA.000000000000...
] |
To evaluate surgical results in patients with COVID-19 |
Retrospective in 2 centers |
468 |
March – April 2020 |
Mainly gynecological and oncological |
55.6% were diagnosed preoperatively |
Higher incidence of serious complications and mortality with previous COVID-19 |
16.7% (with COVID-19) vs. 1.2% (not COVID-19). 23.5% (symptomatic) vs. 10.5% (asymptomatic) |
Ismail[1515 Ismail NA, Jaapar AN, Yunus AM, Sanusi AR, Taib ME, Yakub MA. Outcome of adult cardiac surgery following COVID-19 infection in unvaccinated population in a national tertiary centre. PLoS One. 2022;17(4):e0266056. doi:10.1371/journal.pone.0266056. https://doi.org/10.1371/journal.pone.026...
] |
Surgical results in patients with COVID-19 |
Single center. Retrospective |
12 |
June 2020 – July 2021 |
Cardiac surgery |
Average of 46 days |
Higher incidence of non-invasive ventilation requirement |
Non-major mortality |
Baiocchi[1616 Baiocchi G, Aguiar S Jr, Duprat J P, Coimbra FJF, Makdissi FB, Vartanian JG, et al. Early postoperative outcomes among patients with delayed surgeries after preoperative positive test for SARS-CoV-2: a case-control study from a single institution. J Surg Oncol. 2021;123(4):823-33. doi:10.1002/jso.26377. https://doi.org/10.1002/jso.26377...
] |
Surgical results in patients with a history of asymptomatic COVID-19 |
Retrospective |
49 |
April 2020 – June 2020 |
Oncologic surgery |
25-day average |
No differences in postoperative complications |
No operative mortality |
Deng[1717 Deng JZ, Chan JS, Potter AL, Chen YW, Sandhu HS, Panda N, et al. The risk of postoperative complications after major elective surgery in active or resolved COVID-19 in the United States. Ann Surg. 2022;275(2):242-6. doi:10.1097/SLA.0000000000005308. https://doi.org/10.1097/SLA.000000000000...
] |
Surgical results in patients with COVID-19 |
Retrospective cohort |
2858 |
March 2020 – May 2021 |
All types of surgery excluding emergencies. Vaccinated patients were not included |
Peri-COVID-19 (0-4 weeks), early post-COVID-19 (5-8 weeks), and late post-COVID-19 (after 8 weeks) subgroups |
Greater respiratory complications, pneumonia, thromboembolism, and sepsis in peri-COVID-19. Increased risk of pneumonia in early post-COVID-19 |
Does not report mortality |